Skip to content

GOP Super PAC Ties Montana’s Rob Quist to Nancy Pelosi

Congressional Leadership Fund begins $800,000 media campaign

Screenshot
Screenshot

As national attention turns to the special election in Montana, the super PAC backed by House GOP leadership is deploying House Minority Leader Nancy Pelosi in a new TV attack on Democratic nominee Rob Quist. 

The ad, which will debut Friday on broadcast and cable, marks the start of an $800,000 media buy from Congressional Leadership Fund. The super PAC ran its first TV ad against Quist last month, using many of the same attacks.  

But this new ad adopts the longtime GOP strategy, which CLF has used on TV repeatedly in Georgia in recent weeks, of tying Democratic congressional candidates to Pelosi. 

“Rob Quist talks folksy,” the narrator says, opening the spot. “But his record is more Nancy Pelosi than Montana,” the narrator says. 

“Whether it’s cuts to the military or doubling down on a health care system more expensive than Obamacare, Rob Quist continues to prove he is more in-tune with Nancy Pelosi than Montana,” CLF executive director Corry Bliss said in a statement. 

The ad also goes after Quist’s personal financial troubles, hitting him for a “long pattern of failing to pay his bills” and late taxes. 

“Rob’s reckless financial past is a scary indication of how he’d treat Montanans’ hard-earned dollars. CLF will continue to expose Rob for what he is: out-of-touch and untrustworthy,” Bliss said. 

Quist is running against Republican Greg Gianforte in the special election to fill the at-large congressional seat vacated by former Rep. Ryan Zinke, who’s now serving as secretary of the Interior. 

Recent Stories

GOP readies bills to fund or authorize White House ballroom

One idea to retain Capitol Police officers? Up the retirement age

California man charged in White House media gala shooting

Bipartisan bill would study maternal health-violence link

DeSantis unveils new map aiming to help Florida GOP flip 4 House seats

Immigration debate, upfront costs are hurdles for hepatitis C bill